{"name":"AnnJi Pharmaceutical Co., Ltd.","slug":"annji-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"AnnJi Pharmaceutical Co., Ltd. is a biopharmaceutical company focused on the research and development of innovative therapies. The company currently has three drugs in early-stage clinical trials, targeting various unmet medical needs.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"AJ201","genericName":"AJ201","slug":"aj201","indication":"Other","status":"phase_1"},{"name":"AJ302-IM","genericName":"AJ302-IM","slug":"aj302-im","indication":"Other","status":"phase_1"},{"name":"ALZ002 DS","genericName":"ALZ002 DS","slug":"alz002-ds","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"AJ201","genericName":"AJ201","slug":"aj201","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AJ302-IM","genericName":"AJ302-IM","slug":"aj302-im","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ALZ002 DS","genericName":"ALZ002 DS","slug":"alz002-ds","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwJBVV95cUxQYlZEOC1LdXVCdWJhMnRyMUxZMnh1UFBhOVhPeUVBYzRjNmxwdFZqbElCaVFpV2F4allYcXN0bU5VeFBFOTYxZGVqNjNfR2JMZ2JvSmZmaEVId1M1amF3WXZCTXdHVEdTdHJuT3NQRnpLdDBOMlhSanJpZWJkZkdMYkpkTmxPRXpUaTlSdVZqWFNBS1RKX3Zkc1hYOHpzVXU3cnE4OS04UmlHM2JlVVIwZ1ZBWmhNb29BS3ItSU1WSlpRTDk2RkVxWFZOVFBTODdlRkFZTG5KaVNPLXlNWlRMclZKSEp5NEQ2MzZkd3BOV2k5OHh2NDdfZkhxck4zc1BXZl82bmdWNDktQlA5TVhjMU10T3FiZEx0ZU5F?oc=5","date":"2026-03-04","type":"pipeline","source":"PR Newswire","summary":"Empowering the SBMA Community: AnnJi Highlights Patient & Family Forum and Shares AJ201 Scientific Advancement at the 2026 KDA Conference - PR Newswire","headline":"Empowering the SBMA Community: AnnJi Highlights Patient & Family Forum and Shares AJ201 Scientific Advancement at the 20","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNNFJhUWFvdGFSS096U1RfT3lCaUt0M2o3eVdVa0RCVG9fdW81ZXhCV1hhN0YwMnIyY3lCOFFRa3JDV3hsTzNHVHlGM0tWMzdnWTRrWE1yMGNOSy1jV1FPNWhSejlUWnBITkhNaUF6Rld3cHJEbzJ2SU4wMXd5YVc2d3ljMkN6dUt3aGxCeWtHWjJ2SGhhUzBSakVhYWdiQTVYQVE4elBkVFd2bGs2QmlOQXRNc3A?oc=5","date":"2025-10-13","type":"pipeline","source":"PR Newswire","summary":"AnnJi Showcases Clinical Breakthrough of AJ201 at WMS 2025 - PR Newswire","headline":"AnnJi Showcases Clinical Breakthrough of AJ201 at WMS 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQd1BCUjZKcFJsOWpLZ0ZONjBzUkc1czZ6T0JvbFZFdFk4dkhqZXhRQlRyMU1DeFN4TjlEQ3hMUVBfSS1iTHp0Zm9iTWd3aVFhcWhDeDdRXzFNRFozeEdzbk1naDlCaVRXUnRYRlc0cGl5blhpa1dLUFA5YXZGNjlSa1hEbE9RbC1ndXFIU29wMkdHSE0?oc=5","date":"2025-08-13","type":"pipeline","source":"Pharmaceutical Technology","summary":"Amphastar and Anji make licence agreement for three new peptides - Pharmaceutical Technology","headline":"Amphastar and Anji make licence agreement for three new peptides","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQeV9YWEItRDJ6anpkMlY5dThtS3BBX0JtSUNLeEVFSkFHYktWUW5Lby1sMktyMDJwOWI4SDF2dHdnczJEOVlKWWdTaUhBeUcyeDRDMWRWZktmWE5xUWNuTzMxSGJGSTRnWXFtX3VHNHZPYXZLMngtUmswMnFVaUx1bElRNVZvWEpyVlZCSkhaNjRvTGJRWWotZTFDaWNKN2NibGN3?oc=5","date":"2025-08-12","type":"pipeline","source":"Yahoo Finance","summary":"Amphastar Pharmaceuticals Bolsters Proprietary Pipeline Through Exclusive Licensing Agreement with Nanjing Anji Biotechnology Co., Ltd. - Yahoo Finance","headline":"Amphastar Pharmaceuticals Bolsters Proprietary Pipeline Through Exclusive Licensing Agreement with Nanjing Anji Biotechn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNUFN4Nl96bVBMU2JsWjJucWVCQXI0elA5UEF1RTFYSGUydlJXenNyT2ZyNVhfeTBTcFUtTTd6RGFmSjFVMkdVOVZFd21aT29QMEYzbDF3NDh5Wk9tTkxJRTJiVWJIT2kyRXo2ZmFXM0cwSGxwUFowV1lVQ2tOQU1OY2tfMngwTmNZSEVqRkxOSElJZ3fSAZgBQVVfeXFMT0RpNW5WVEo4bHZ3NDlrbWFDVG9GYUwtN2xsWUNNbzU2TFAwVXVqN1BPQkhDTHlZbENMNzJxb0RvVzUtcDZqTW5xQ0pWM21wRDQ0bzlTZmpLNURSQ3V3dDBRZ2dLckJJaEJmWm96UnpEbXlOeXNSbVJCV1o5ckt4WVVlWmVlNms5dE8yZFFfdVZQd1BjSkNmS2E?oc=5","date":"2025-06-19","type":"pipeline","source":"Forbes India","summary":"Top 10 pharma companies in India by market cap [2025] - Forbes India","headline":"Top 10 pharma companies in India by market cap [2025]","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxOTTJRa25DNDFUQ3pkaGRjR3o1NzdQY21nY2VYcEpKXzBJMjJxZjZacTBkV2VfYktaVFZsS1RKZ1BjVWhza1FYbUNjX3dMbGdQYXVEcjk3WFJDM0R5N09pZ2NxXzVzZV9zamJtLVNGMHo0aUJHWXNUeG90dGVNdGJUVFJaLUhrc0tpTVhJYmp1am9zSUZBc0ZZQXlxekR3OXdoR0VFdFA5REg2VHVQaTFaeU9YQXR6ZV9QS0NLNVEybEh0OEo2Z1FvUzluZw?oc=5","date":"2025-05-22","type":"trial","source":"BioPharma APAC","summary":"AnnJi Reports Promising Phase 1/2a Results for AJ201 in Rare Neuromuscular Disease SBMA - BioPharma APAC","headline":"AnnJi Reports Promising Phase 1/2a Results for AJ201 in Rare Neuromuscular Disease SBMA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1VNHVrcUtkeU9sV0RNOVU2VVZibXhqUy14cUo1QVJPVXpEXzc3NGlvNWF4NlN4ZnoyQ0h4YXAtY1pYZjFNS0tTM0hZQ3BfZngweUlv?oc=5","date":"2025-04-24","type":"pipeline","source":"Stock Titan","summary":"AMPH Stock Price, News & Analysis - Stock Titan","headline":"AMPH Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPRWYzMkNnbWZxc3RFUkFTZHNQNTZDSDJ1ZWdoZ05RWk0wVVBMd0RyZHFGQmFZSkNJNzZmcHduQUFnUFB5ZWZlNS1zeWlxN1lROHprdzFlRko4TjBENWhBRnFmX0E1RmJ2bnpTUWVtSTVJR3pDRnphQm00WHBMRVo2R2JPLTFKYjlZS09sOFl2NzlzdTJl?oc=5","date":"2024-11-05","type":"pipeline","source":"Yahoo Finance","summary":"Global Alopecia Treatment Market is Anticipated to Surpass ~USD 4 Billion by 2030 | DelveInsight - Yahoo Finance","headline":"Global Alopecia Treatment Market is Anticipated to Surpass ~USD 4 Billion by 2030 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxPT2tqdDNfdjM3eU5vaHBDbDFRM2xEX2ZjR21NWXJfbWNvcVlad1VNTjdGbTI0M1p0Q3NSSHJCOU9aQXQ5ckVGY2t0UnU5R0FEVmwwUXRFbmxhTGlQVzdFSl9sYVJBNGstQTlwd25UQlp1aFh4MmNMMlRGOGF2eU5KdWNDdGd1X1Z2X2E3U0J2V2RaWHFoVFJFNHVackpoZ3JxRzZ4RGQwdHU4eS1WSEF6TmI1TXBlRTdFSWxkVjZJelQ0dlpzci1CRWRzYk1uQ0pzNUVfZ0MyYllKd090YnZhUE9GaFZLRXozbmR4WU05UQ?oc=5","date":"2023-03-13","type":"pipeline","source":"BioPharma APAC","summary":"AnnJi Pharma and Avenue Therapeutics Enter Licensing Agreement for Clinical Asset AJ201 to Treat Kennedy's Disease. - BioPharma APAC","headline":"AnnJi Pharma and Avenue Therapeutics Enter Licensing Agreement for Clinical Asset AJ201 to Treat Kennedy's Disease.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNTnliMTZNM3l5Njh2TFEzc0tLOUdSck1IaWVkVjBzMUlfRzlXelVTQTJYOV92OGZGd1NQSlBtT2FDX0J4TjhuUHNGZzNDYkw3T3J3Qk5xWUdvMnBWT041cEpKUWQzb2tYN0FXd0ZzY2hSb2xsLVY3aldueDVyNmFSeGtBdV9JTFo2Y0s3UmZ1a1pLM2VNUTVtaEhtZ3I2RWJ3eUE?oc=5","date":"2022-08-30","type":"trial","source":"globaldata.com","summary":"Idiopathic Pulmonary Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - globaldata.com","headline":"Idiopathic Pulmonary Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Upda","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxNd0ZuZl9TZDkxa19MTnpxSjJWLUozbTZiNTRnZlBoMjdVeVpJcEo3TVZQV3dWTEw5ZDdBc0FXTHRzbGpJZUR0WHo0QU1IZ0xzQm1QdnAxdWZ0c05ZcFN1dWJjdGZreV9hTjAxOV9mNnZjdzRHV3gwUE9zUmpKa1ZqSU5abUpMajF5MHV3aVhJRURZRDJNM1dITWhlVFdoQkFYR0VEdk5uNHk1R2hLaHJ2c0YzM2dxZk9BWGdFU2x2clBheHowMk5hbThydl9fSWtxc1VlekFRb2pfVWpyUkx4VG1LbkcwWmUyZFo3cHBHQnF4QQ?oc=5","date":"2021-09-28","type":"pipeline","source":"Business Wire","summary":"Anji Pharma Secures $70 Million to Deploy Dynamic Equity and Further Build a Global Medicines Company - Business Wire","headline":"Anji Pharma Secures $70 Million to Deploy Dynamic Equity and Further Build a Global Medicines Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOaGVsVGNjRXhMbkQyNml6VnFLRGtYOXAzVXBSWEplaC01VVJzWUk5TFVXc2NCbGJkOGJIaHNKU1lJanhDWG8zZGhqaENnNGxad2dJVG9YUDhCME41c19obEljWHozZ2V4Vm5NWXQtaHBSd0lORjJad2RSaExyQ1JGYkJ4YjRsRnoyZFdZQWZXTXk?oc=5","date":"2017-07-19","type":"pipeline","source":"The American Bazaar","summary":"Top five Indian pharma companies with plants in the US - The American Bazaar","headline":"Top five Indian pharma companies with plants in the US","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_1":3},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}